SYNEURX Trademark

Trademark Overview


On Friday, July 1, 2016, a trademark application was filed for SYNEURX with the United States Patent and Trademark Office. The USPTO has given the SYNEURX trademark a serial number of 87091025. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, September 20, 2024. This trademark is owned by SyneuRx International Corp.. The SYNEURX trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical products and substances for treating neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; medicines for neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; pharmaceutical preparations for neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; sodium salts for medical purposes

Pharmaceutical preparations and drug development services for developing drugs for treating neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Biological research; Clinical lab test of medical reagents for conducting clinical trials for others in the field of neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Scientific research and analysis in the field of medical reagents; Providing research and development of technology in the field of neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Technical research in the field of neuropsychiatric disorders, namely, schizophrenia, dep...
syneurx

General Information


Serial Number87091025
Word MarkSYNEURX
Filing DateFriday, July 1, 2016
Status710 - CANCELLED - SECTION 8
Status DateFriday, September 20, 2024
Registration Number5419038
Registration DateTuesday, March 6, 2018
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, May 23, 2017

Trademark Statements


Description of MarkThe mark consists of the stylized word "SYNEURX".
Goods and ServicesPharmaceutical products and substances for treating neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; medicines for neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; pharmaceutical preparations for neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; sodium salts for medical purposes
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesPharmaceutical preparations and drug development services for developing drugs for treating neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Biological research; Clinical lab test of medical reagents for conducting clinical trials for others in the field of neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Scientific research and analysis in the field of medical reagents; Providing research and development of technology in the field of neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Technical research in the field of neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Technical project studies in the field of neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Scientific laboratory services

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, September 20, 2024
Primary Code005
First Use Anywhere DateSaturday, May 31, 2014
First Use In Commerce DateSaturday, May 31, 2014

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, September 20, 2024
Primary Code042
First Use Anywhere DateMonday, March 14, 2016
First Use In Commerce DateMonday, March 14, 2016

Trademark Owner History


Party NameSyneuRx International Corp.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressTaipei City 110
TW

Party NameSyneuRx International Corp.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTaipei City 110
TW

Party NameSyneuRx International Corp.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTaipei City 110
TW

Trademark Events


Event DateEvent Description
Thursday, October 13, 2016NON-FINAL ACTION WRITTEN
Tuesday, July 5, 2016NEW APPLICATION ENTERED
Wednesday, July 6, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, October 12, 2016ASSIGNED TO EXAMINER
Thursday, October 13, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, October 13, 2016NON-FINAL ACTION E-MAILED
Friday, March 31, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, March 31, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, April 1, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 14, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 3, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 23, 2017PUBLISHED FOR OPPOSITION
Tuesday, May 23, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 18, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, January 18, 2018TEAS STATEMENT OF USE RECEIVED
Thursday, January 18, 2018USE AMENDMENT FILED
Tuesday, January 30, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, January 30, 2018STATEMENT OF USE PROCESSING COMPLETE
Tuesday, January 30, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, January 31, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, March 6, 2018REGISTERED-PRINCIPAL REGISTER
Friday, December 23, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, December 23, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, December 23, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Friday, December 23, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, December 28, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, December 28, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, December 28, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, December 28, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, December 28, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, December 28, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, December 28, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, December 28, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, March 6, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, September 20, 2024CANCELLED SEC. 8 (6-YR)